Ajanta Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 - Marketscreener.com
| AJANTPHARM | 3,023 92.20 3.15% |
Under 55% of Ajanta Pharma's traders are presently thinking to get in. The analysis of overall sentiment of trading Ajanta Pharma Limited stock suggests that some investors are interested at this time. Ajanta Pharma's investing sentiment shows overall attitude of investors towards Ajanta Pharma Limited.
Ajanta |
Ajanta Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 Marketscreener.com
Read at news.google.com
 |
Ajanta Pharma Fundamental Analysis
We analyze Ajanta Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ajanta Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ajanta Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Ajanta Pharma is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Ajanta Pharma Limited Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ajanta Pharma stock to make a market-neutral strategy. Peer analysis of Ajanta Pharma could also be used in its relative valuation, which is a method of valuing Ajanta Pharma by comparing valuation metrics with similar companies.
Peers
Ajanta Pharma Related Equities
| KAVVERITEL | Kavveri Telecom | 5.00 | ||||
| TOTAL | Total Transport | 3.34 | ||||
| TATACOMM | Tata Communications | 0.58 | ||||
| PNC | Pritish Nandy | 0.42 | ||||
| ADFFOODS | ADF Foods | 0.09 | ||||
| BFUTILITIE | BF Utilities | 0.22 | ||||
| UNIINFO | Uniinfo Telecom | 0.74 | ||||
| ORTEL | Ortel Communications | 5.38 |
Complementary Tools for Ajanta Stock analysis
When running Ajanta Pharma's price analysis, check to measure Ajanta Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ajanta Pharma is operating at the current time. Most of Ajanta Pharma's value examination focuses on studying past and present price action to predict the probability of Ajanta Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ajanta Pharma's price. Additionally, you may evaluate how the addition of Ajanta Pharma to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |